1. Performance of the multitarget Mikrogen Chlamydia trachomatis IgG ELISA in the prediction of tubal factor infertility (TFI) in subfertile women: comparison with the Medac MOMP IgG ELISA plus.
- Author
-
van Ess EF, Ouburg S, Spaargaren J, Land JA, and Morré SA
- Subjects
- Adult, Case-Control Studies, Chlamydia Infections complications, Chlamydia Infections microbiology, Chlamydia Infections pathology, Chlamydia trachomatis pathogenicity, Chlamydia trachomatis physiology, Enzyme-Linked Immunosorbent Assay, Fallopian Tubes microbiology, Female, Humans, Hysterosalpingography, Infertility, Female complications, Infertility, Female microbiology, Infertility, Female pathology, Laparoscopy, Sensitivity and Specificity, Tissue Adhesions complications, Tissue Adhesions microbiology, Tissue Adhesions pathology, Antibodies, Bacterial blood, Chlamydia Infections diagnosis, Fallopian Tubes pathology, Immunoglobulin G blood, Infertility, Female diagnosis, Tissue Adhesions diagnosis
- Abstract
There is a need for more accurate Chlamydia trachomatis (CT) IgG antibody tests for tubal factor infertility (TFI) diagnostics. We evaluated the predictive value for TFI of Medac ELISA plus (MOMP) and multitarget Mikrogen ELISA (MOMP-CPAF-TARP). Based on Medac ELISA plus results, 183 subfertile women underwent either hysterosalpingography or laparoscopy to diagnose TFI. TFI was defined as extensive adhesions and/or distal occlusion of at least one tube. Women not fulfilling the definition of TFI served as controls. Serum was subsequently tested with Mikrogen ELISA and results were compared. 48 patients had TFI, 135 were controls. Mikrogen ELISA tested 125 patients positive/borderline of which 32% had TFI. Medac ELISA plus tested 77 patients positive/borderline of which 29.9% had TFI. Mikrogen tested 40 out of 48 TFI patients positive/borderline, Medac 23 out of 48. Kappa value was 0.34. PPV of Mikrogen ELISA and Medac ELISA plus were respectively 32% (95% CI 26%-39%) and 30% (95% CI 24%-37%), and NPV 86% (95% CI 81%-91%) and 76% (95% CI 70%-82%). Both tests were comparable in the prediction of TFI. However, Mikrogen ELISA had a higher NPV and might be more reliable in identifying patients without TFI. Kappa-value showed limited concordance between both tests., (© FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2017
- Full Text
- View/download PDF